Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Licenses Genetic ID Tech to Ghent University Microbiology Lab

NEW YORK (GenomeWeb News) — Keygene has licensed some of its genomic technology to a research group in Ghent University in Belgium, Keygene said Tuesday.
 
The five-year, non-exclusive agreement allows the Belgian Coordinated Collection of Microorganisms at the Laboratory for Microbiology at Ghent University, or BCCM/LMG, to use Keygene’s AFLP technology to “extend its genetic database” and “serve its customers with AFLP typing of bacterial stains.”
 
AFLP is a DNA marker technology for genome analysis, transcript profiling, and genetic analysis. BCCM/LMG manages bacterial strains for the Belgian BCCM Consortium.
 
Ghent University used the technology in the early 1990s to build its bacterial database, said BCCM/LMG director Paul de Vos.
 
Financial terms of the agreement were not released.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.